Hightide Therapeutics Inc (HK:2511) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
HighTide Therapeutics Inc. has announced a change in its joint company secretary position, with Ms. Gao Liping taking over the role from Ms. Yu Li as of December 19, 2024. While Ms. Gao lacks the formal qualifications typically required, the company has received a waiver from the Hong Kong Stock Exchange due to her extensive experience and familiarity with the company’s operations. This strategic move underscores HighTide’s commitment to leveraging internal talent to support its growth in the pharmaceutical sector.
For further insights into HK:2511 stock, check out TipRanks’ Stock Analysis page.